يعرض 1 - 20 نتائج من 48 نتيجة بحث عن '"Serum zinc levels"', وقت الاستعلام: 0.52s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal

    المصدر: Nutrients; Volume 12; Issue 10; Pages: 3187

    مصطلحات موضوعية: serum zinc levels, hemodialysis, nutritional status

    جغرافية الموضوع: agris

    وصف الملف: application/pdf

    Relation: Micronutrients and Human Health; https://dx.doi.org/10.3390/nu12103187

  7. 7
    Conference

    المساهمون: Gomez Contreras, María Camila 0001664780, Albarracín Ruiz, María José 0001649451, Cano Rosales, Diana Jimena 0000947237, Gomez Contreras, María Camila 0000-0003-0542-4622, Bernal Alarcón, Diego Nicolás 0000-0003-2072-9731, Cano Rosales, Diana Jimena 0000-0002-7090-5142, Semilleros de Investigación UNAB

    المصدر: Gomez, M. C., et al. (2018). Niveles De Zinc En Pacientes Con Epoc Fenotipo Exacerbador. Recuperado de: http://hdl.handle.net/20.500.12749/21674

    Time: 2018

    وصف الملف: application/pdf

    Relation: Generación Creativa : Encuentro de Semilleros de Investigación UNAB; http://hdl.handle.net/20.500.12749/14242; 1. Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017 Mar;195(5):557–82.; 2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (London, England). 2012 Dec;380(9859):2095–128.; 3. WHO %7C The global burden. WHO [Internet]. 2010 [cited 2017 Sep 21]; Available from: http://who.int/substance_abuse/facts/global_burden/en/; 4. Partridge MR, Miravitlles M, Stahl E, Karlsson N, Svensson K, Welte T. Development and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPD. Eur Respir J [Internet]. 2010 Jul 1 [cited 2017 Sep 21];36(1):96–104. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19897551; 5. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J [Internet]. 2009 May 1 [cited 2017 Sep 21];33(5):1165–85. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19407051; 6. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet [Internet]. 2007 Sep 1 [cited 2017 Sep 21];370(9589):797–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17765529; 7. Rerksuppaphol S, Rerksuppaphol L. Zinc Supplementation in Children with Asthma Exacerbation. Pediatr Rep [Internet]. 2016 Nov 17 [cited 2017 Sep 21];8(4):6685. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28058103; 8. Riccioni G, D’Orazio N. The role of selenium, zinc and antioxidant vitamin supplementation in the treatment of bronchial asthma: adjuvant therapy or not? Expert Opin Investig Drugs [Internet]. 2005 Sep 22 [cited 2017 Sep 21];14(9):1145–55. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16144498; 9. Guo C-H, Liu P-J, Lin K-P, Chen P-C. Nutritional supplement therapy improves oxidative stress, immune response, pulmonary function, and quality of life in allergic asthma patients: an open-label pilot study. Altern Med Rev [Internet]. 2012 Mar [cited 2017 Sep 19];17(1):42–56. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22502622; 11. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet [Internet]. 2004 Aug [cited 2017 Sep 14];364(9434):613– 20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15313363; 12. Raherison C, Girodet P-O. Epidemiology of COPD. Eur Respir Rev [Internet]. 2009 [cited 2017 Sep 13];18(114). Available from: http://err.ersjournals.com/content/18/114/213#T2; 13. Menezes AMB, Perez-Padilla R, Jardim JRB, Muiño A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet (London, England). 2005 Nov;366(9500):1875–81.; 14. Caballero A, Torres-Duque CA, Jaramillo C, Bolívar F, Sanabria F, Osorio P, et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest. 2008;133(2):343–9.; 16. Jenkins CR, Jones PW, Calverley PM, Celli B, Anderson JA, Ferguson GT, et al. Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebocontrolled TORCH study. Respir Res [Internet]. 2009 Dec 30 [cited 2017 Sep 14];10(1):59. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19566934; 17. Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP, et al. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet [Internet]. 2009 Oct 3 [cited 2017 Sep 14];374(9696):1171–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19716598; 18. Soler-Cataluna JJ, Martínez-García MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax [Internet]. 2005 Nov 1 [cited 2017 Sep 14];60(11):925–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16055622; 19. Pauwels RA, Löfdahl C-G, Laitinen LA, Schouten JP, Postma DS, Pride NB, et al. Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking. N Engl J Med. 1999 Jun;340(25):1948–53.; 20. Vestbo J, Sørensen T, Lange P, Brix A, Torre P, Viskum K. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (London, England). 1999 May;353(9167):1819–23.; 22. O’Donnell DE, Flüge T, Gerken F, Hamilton A, Webb K, Aguilaniu B, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J. 2004;23(6).; 23. O’Donnell DE, Sciurba F, Celli B, Mahler DA, Webb KA, Kalberg CJ, et al. Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and Exercise Endurance in COPD. Chest. 2006 Sep;130(3):647–56.; 24. Zalewski PD, Truong-Tran AQ, Grosser D, Jayaram L, Murgia C, Ruffin RE. Zinc metabolism in airway epithelium and airway inflammation: Basic mechanisms and clinical targets. A review. Pharmacol Ther. 2005;105(2):127–49.; 25. Zalewski PD. Zinc metabolism in the airway: basic mechanisms and drug targets. Curr Opin Pharmacol. 2006;6(3):237–43.; 26. Daga MK, Chhabra R, Sharma B, Mishra TK. Effects of exogenous vitamin E supplementation on the levels of oxidants and antioxidants in chronic obstructive pulmonary disease. J Biosci [Internet]. 2003 Feb [cited 2017 Sep 19];28(1):7–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12682418; 28. Di Toro R, Galdo Capotorti G, Gialanella G, Miraglia del Giudice M, Moro R, Perrone L. Zinc and copper status of allergic children. Acta Paediatr Scand [Internet]. 1987 Jul [cited 2017 Sep 19];76(4):612–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3630679; 29. Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Garg ML. Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma. Lipids [Internet]. 2000 Sep [cited 2017 Sep 19];35(9):967– 74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11026617; 30. el-Kholy MS, Gas Allah MA, el-Shimi S, el-Baz F, elTayeb H, Abdel-Hamid MS. Zinc and copper status in children with bronchial asthma and atopic dermatitis. J Egypt Public Health Assoc [Internet]. 1990 [cited 2017 Sep 19];65(5–6):657–68. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2134100; 31. Kadrabová J, Mad’aric A, Podivínsky F, Gazdík F, Ginter F. Plasma zinc, copper and copper/zinc ratio in intrinsic asthma. J Trace Elem Med Biol [Internet]. 1996 Apr [cited 2017 Sep 19];10(1):50–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8793823; 32. Kirkil G, Hamdi Muz M, Seçkin D, Sahin K, Küçük O. Antioxidant effect of zinc picolinate in patients with chronic obstructive pulmonary disease. Respir Med [Internet]. 2008;102(6):840–4. Available from: www.pubmed.gov; http://hdl.handle.net/20.500.12749/21674; instname:Universidad Autónoma de Bucaramanga - UNAB; reponame:Repositorio Institucional UNAB; repourl:https://repository.unab.edu.co

  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
  12. 12
    Academic Journal
  13. 13
    Academic Journal
  14. 14
    Academic Journal
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20